Invitae (NYSE: NVTA), a leading medical genetics company, today announced the upcoming departure of Chief Financial Officer (CFO) Yafei (Roxi) Wen. Ms. Wen will step down from her role effective June 30, 2023, to pursue other opportunities, and the Company has initiated a search for a new CFO.
To ensure a smooth transition, Christine Gorjanc, Invitae’s longtime Board of Directors Audit Committee Chair, will take on the role of interim CFO from July 1, 2023. Ms. Wen has an amicable departure from Invitae and will remain with the executive team to ensure a successful handoff.
We are immensely grateful for Roxi’s significant contributions to the Company over the past two years, and are thankful for her help during the transition. We wish her all the best in her future endeavors.
We are fortunate to have Christine stepping in at this juncture, with her wealth of CFO experience in publicly-traded companies, deep understanding of finance and accounting, and lengthy tenure as the Chair of our Audit Committee with the Invitae Board of Directors – making her an invaluable resource for Invitae as we continue our search for a new CFO.
Ms. Gorjanc has been a pillar of the Company’s Board of Directors since November 2015, additionally serving as Chair of the Audit Committee. Before joining Arlo Technologies, Inc. in August 2018 as CFO and holding the post until June 2020, she had been CFO of NETGEAR, Inc. since January 2008, where she also held the roles of chief accounting officer and vice president of Finance.
Ms. Wen expressed her gratitude for the opportunity to collaborate with such outstanding teams, adding that she has utmost faith in Christine’s capacities to guide the company forward and manifest its promising vision.
At Invitae (NYSE: NVTA), we believe in using the power of digital technology to provide medical genetic information that is both accurate and actionable. We strive to empower individuals and their families to make well-informed healthcare decisions by providing genetic expertise that is science-based and reliable. Invitae is dedicated to giving billions of people access to genomic information that will enable them to make meaningful decisions and improve their overall well-being.